Injective currently has three ETF applications in the US that have not yet been approved and are under review by the SEC.
https://x.com/21shares — a spot Injective ETF, proposed ticker TINJ, to be listed on Nasdaq.
https://x.com/CanaryFunds — the Canary Staked INJ ETF, proposed ticker INJS, to be listed on Cboe BZX.
https://x.com/REXShares — the REX-Osprey INJ Staking ETF. The Block and industry reports list it as the third application alongside 21Shares and Canary.
Three independent issuers want to give US investors regulated access to $INJ , and in some cases to staking yield as well.
Amendments filed in September show the process is moving, and approval could come soon. In early October, Injective CEO Eric Chen said a launch before 2027 looks more realistic than a later date, though no specific timeline has been given. #Altcoin Season#
https://x.com/21shares — a spot Injective ETF, proposed ticker TINJ, to be listed on Nasdaq.
https://x.com/CanaryFunds — the Canary Staked INJ ETF, proposed ticker INJS, to be listed on Cboe BZX.
https://x.com/REXShares — the REX-Osprey INJ Staking ETF. The Block and industry reports list it as the third application alongside 21Shares and Canary.
Three independent issuers want to give US investors regulated access to $INJ , and in some cases to staking yield as well.
Amendments filed in September show the process is moving, and approval could come soon. In early October, Injective CEO Eric Chen said a launch before 2027 looks more realistic than a later date, though no specific timeline has been given. #Altcoin Season#